Drug Repositioning Efforts by Nonprofit Foundations
- 8 April 2012
- other
- Published by Wiley
- p. 389-431
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with l -dopa–induced dyskinesiaProceedings of the National Academy of Sciences, 2010
- L‐type calcium channel blockers and Parkinson disease in DenmarkAnnals of Neurology, 2010
- Genome-wide association study reveals genetic risk underlying Parkinson's diseaseNature Genetics, 2009
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseNew England Journal of Medicine, 2009
- Autosomal dominant polycystic kidney disease: the last 3 yearsKidney International, 2009
- Biological substrates of reward and aversion: A nucleus accumbens activity hypothesisNeuropharmacology, 2009
- The cost of biopharmaceutical R&D: is biotech different?Managerial and Decision Economics, 2007
- Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivinProceedings of the National Academy of Sciences, 2006
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998